All posts by: Michael Zand

About Michael Zand

Gene Therapy Trial Doses First DMD Patient – Rare Disease Report

Continue reading

2018-01-25 NEWS

Rare Disease Report

Gene Therapy Trial Doses First DMD Patient
Rare Disease Report
… create a brighter future for these children,” said Douglas Ingram, Sarepta’s president and chief executive officer. “Sarepta is the world leader in precision genetic medicine to treat DMD, spanning RNA-targeted therapies, gene therapy, and gene

Continue reading

2018-01-25 NEWS

Sportsnet.ca

Q&A: Graham DeLaet on stem cell treatment, Timbits, beer and Tiger
Sportsnet.ca
DeLaet reveled on Twitter last week he had an intradiscal stem cell injection – he told Sportsnet.ca that the treatment occurred at a clinic in California – and he had yet to recover. It remains to be seen when he’ll be returning to action on the PGA

and more »